Cheng-Ho Jimmy Lin - 20 Jul 2026 Form 3 Insider Report for Freenome, Inc. (FRNM)

Reporting relationship
Chief Scientific Officer
Issuer ticker
FRNM
Reported as of
20 Jul 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
27 Jul 2026, 20:48:14 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Fitzpatrick, Attorney-in-Fact

Key filing fact

Cheng-Ho Jimmy Lin filed Form 3 for Freenome, Inc. (FRNM) on 27 Jul 2026.

Key facts

  • This page summarizes Cheng-Ho Jimmy Lin's Form 3 filing for Freenome, Inc. (FRNM).
  • 0 reported transactions and 6 derivative rows are listed below.
  • Accepted by SEC: 27 Jul 2026, 20:48.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002146103 Primary reporting owner

Lin Cheng-Ho Jimmy

Relationship
Chief Scientific Officer
Address
C/O FREENOME, INC., 51 ASTOR PLACE, 10TH FLOOR, NEW YORK
Signature
/s/ Thomas Fitzpatrick, Attorney-in-Fact
Signature date
27 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FRNM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
410,154
Date
20 Jul 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

FRNM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,849
Exercise price
$4.85
Footnotes
F1
FRNM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
145,561
Exercise price
$4.85
Footnotes
F1
FRNM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
140,685
Exercise price
$15.91
Footnotes
F1, F5
FRNM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
49,651
Exercise price
$11.88
Footnotes
F2, F5
FRNM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
78,331
Exercise price
$18.24
Footnotes
F3, F5
FRNM holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
20 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
150,019
Exercise price
$14.00
Footnotes
F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The shares subject to this option are fully vested.

Footnote F2

25% of the shares subject to this option shall vest and become exercisable on February 2, 2024 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Footnote F3

The shares subject to this option shall vest and become exercisable in thirty-six (36) equal monthly installments commencing from February 16, 2024, subject to the Reporting Person's continued service on each such vesting date.

Footnote F4

25% of the shares subject to this option shall vest and become exercisable on February 15, 2026 with the remainder vesting in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Footnote F5

This option was previously amended, pursuant to which the exercise price of the option will be automatically reduced to $8.45 upon the occurrence of certain events.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .